FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2017/11/010546 [Registered on: 17/11/2017] Trial Registered Retrospectively
Last Modified On: 17/11/2017
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Amount of desflurane used at three different flow rates 
Scientific Title of Study   Comparison of efficacy and evaluation of the optimal flow rate for desflurane anaesthesia at three different settings 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Meenoti Potdar 
Designation  Consultant Anaesthesiologist 
Affiliation  Dr. Lakhumal Hiranand Hiranandani Hospital 
Address  Department of Anaesthesia,
Hiranandani Gardens, Hillside Avenue, Powai
Mumbai (Suburban)
MAHARASHTRA
400076
India 
Phone  9920627839  
Fax    
Email  meenoti@yahoo.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Meenoti Potdar 
Designation  Consultant Anaesthesiologist 
Affiliation  Dr. Lakhumal Hiranand Hiranandani Hospital 
Address  Department of Anaesthesia,
Hiranandani Gardens, Hillside Avenue, Powai
Mumbai (Suburban)
MAHARASHTRA
400076
India 
Phone  9920627839  
Fax    
Email  meenoti@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Dr Meenoti Potdar 
Designation  Consultant Anaesthesiologist 
Affiliation  Dr. Lakhumal Hiranand Hiranandani Hospital 
Address  Department of Anaesthesia,
Hiranandani Gardens, Hillside Avenue, Powai
Mumbai (Suburban)
MAHARASHTRA
400076
India 
Phone  9920627839  
Fax    
Email  meenoti@yahoo.com  
 
Source of Monetary or Material Support  
Dr L H Hiranandani Hospital 
 
Primary Sponsor  
Name  Dr L H Hiranandani Hospital 
Address  Hillside Avenue Hiranandani gardens Powai Mumbai 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Meenoti Potdar  Operation theatre  Dr L H Hiranandani Hospital 2nd floor Hillside Avenue Hiranandani Gardens Powai Mumbai-400076
Mumbai (Suburban)
MAHARASHTRA 
9920627839

meenoti@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional ethics committee Dr L H Hiranandani Hospital Powai   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  ASA Grade I and 2, non pregnant patients, of both sexes, in the age group of 18 to 70 years, consenting for general anaesthesia for laprascopic surgery lasting for 30 minutes to 3 hours,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Desflurane at 0.5 litres of flow rate for maintenance of general anaesthesia  General anaesthesia would be maintained by titrating desflurane at a flow rate of 0.5 litres to maintain an entropy value between 40-60. 
Intervention  Desflurane at 1 litres of flow rate for maintenance of general anaesthesia  General anaesthesia would be maintained by titrating desflurane at a flow rate of 1 litres to maintain an entropy value between 40-60. 
Comparator Agent  Desflurane at 1.5 litres of flow rate for maintenance of general anaesthesia  General anaesthesia would be maintained by titrating desflurane at a flow rate of 1.5 litres to maintain an entropy value between 40-60. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  1. ASA 1 and 2 patients undergoing General anaesthesia for laprascopic abdominal and pelvic
surgeries
2. Surgeries lasting approximately 30 minutes to 180 minutes
3. Patients giving valid consent
4. Age:18 to 70 year
 
 
ExclusionCriteria 
Details  •Patient refusal
•ASA grade >2
•Chronic alcoholics/ smokers, acute alcohol intoxication
•Pregnant women
•Patients with neuromuscular diseases
•Suspected Malignant hyperthermia
•Persons with epidural analgesia catheter
 
 
Method of Generating Random Sequence   Random Number Table 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
Efficacy of desflurane with respect to maintenance haemodynamic parameters and depth of anaesthesia  At all time points intraoperatively after starting desflurane to switching off desflurane 
 
Secondary Outcome  
Outcome  TimePoints 
1. Safety of low flow rates assessed by oxygenation of the patient
2. Incidence of awareness under anaesthesia
3. Consumption of desflurane
4. Recovery parameters of the patient after stopping desflurane like time for extubation, time for response to oral commands and time taken for eye opening 
1. Throughout intraoperatively
2. Post operatively in the recovery room and after 24 hours
3. After stopping desflurane
4. After stopping desflurane 
 
Target Sample Size   Total Sample Size="150"
Sample Size from India="150" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   01/07/2015 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   Not yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   This study is conducted to evaluate the optimal flow rate for using desflurane at low flows, its efficay for maintenance of depth of anaesthesia and haemodynamic stability. We would like to evaluate that by decreasing the flow rates does the consumption of desflurane actually reduces. We would also like to highlight the safety of oxygenation with low flow rates and the recovery out come of the patient post stopping desflurane. 
Close